US-listed shares of GW Pharmaceuticals rose 8% on Thursday as its marijuana-based treatment Epidiolex cleared the last hurdle after the Drug ... read more
GW Pharma cannabis drug set to hit market following DEA nod
GW Pharma cannabis drug set to hit market following DEA nod